Skip to main content
CCL Products (India) Ltd. logo

CCL Products (India) Ltd. — Investor Relations & Filings

Ticker · CCL ISIN · INE421D01022 LEI · 3358004YMWO3ILPLLM24 BSE.NS Manufacturing
Open in API
Filings indexed 1,203 across all filing types
Latest filing 2024-11-05 Regulatory Filings
Country IN India
Listing BSE.NS CCL

About CCL Products (India) Ltd.

https://www.cclproducts.com

CCL Products (India) Ltd. is a global manufacturer and exporter specializing in instant coffee production. The company provides a comprehensive range of products, including spray-dried coffee powder, freeze-dried coffee, coffee granules, and roasted coffee beans. It operates advanced processing facilities to supply customized coffee solutions to private labels, major retailers, and institutional clients across more than 90 international markets. The product portfolio encompasses pure coffee and chicory-blended varieties, designed to meet specific quality standards. By utilizing large-scale production capacities and sophisticated processing technologies, the organization maintains a significant role in the global supply chain, focusing on product consistency and technical excellence for diverse market requirements.

Recent filings

Filing Released Lang Actions
The outcome of the meeting is attached herewith
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) reporting the outcome of a Board Meeting. It specifically states that the Board approved the unaudited standalone and consolidated financial results for the second quarter and half year ended 30th September 2024. The document is short (1712 characters) and serves as an announcement of the approval of financial results rather than containing the full financial statements or detailed analysis. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement informing the exchanges and public about the board's approval of interim financial results, but does not itself contain the full interim report or detailed financial data. Therefore, the correct classification is Regulatory Filings (RNS).
2024-11-05 English
Financial Result Updates
Regulatory Filings
2024-11-05 English
Outcome of Board Meeting
Regulatory Filings Classification · 95% confidence The document is a formal communication addressed to stock exchanges (NSE and BSE) reporting the outcome of a Board Meeting. It specifically states that the Board approved the unaudited standalone and consolidated financial results for the second quarter and half year ended 30th September 2024. The document is short (1712 characters) and serves as an announcement of the approval of financial results rather than containing the full financial statements or detailed analysis. This fits the profile of an Interim / Quarterly Report announcement or outcome notice. However, since it does not contain the actual financial data or detailed report but only the approval and outcome, it is best classified as a Regulatory Filing (RNS) under the fallback rule for announcements that do not contain full report content.
2024-11-05 English
We wish to inform that the Investors concall shall be held on 06.11.2024 at 11:00 AM
Call Transcript Classification · 95% confidence The document is a notification to stock exchanges about a scheduled conference call to discuss the unaudited financial results for the second quarter ended September 30, 2024. It includes details about the date, time, participants, and dial-in information for the call. The document does not contain any financial data or analysis itself, but rather announces the upcoming event where such information will be discussed. The document length is 3106 characters, which is relatively short and consistent with an announcement rather than a full report or transcript. Therefore, this document is best classified as a Call Transcript (CT) announcement or invitation. However, since it is only the schedule and invitation for the call and not the transcript itself, it fits best under Regulatory Filings (RNS) as a general regulatory announcement about the call. But given the specific nature of the announcement about the conference call for earnings results, the most appropriate classification is Call Transcript (CT) as it directly relates to the earnings call event.
2024-11-02 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is a notification addressed to stock exchanges about a scheduled conference call to discuss the unaudited financial results for the second quarter ended 30th September 2024. It includes details about the date and time of the call, participants from the company's management, and dial-in information. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is an announcement of an upcoming event related to financial results discussion, not the results or report itself. Therefore, this document is best classified as a Call Transcript (CT) announcement or invitation. However, since it is only the schedule and invitation for the conference call and not the transcript itself, the closest fitting category is Call Transcript (CT) as it relates directly to the conference call event. Confidence is high due to clear references to the conference call and financial results discussion.
2024-11-02 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2024-10-28 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.